These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26055750)

  • 21. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
    Maves RC; Castillo R; Guillen A; Espinosa B; Meza R; Espinoza N; Núñez G; Sánchez L; Chacaltana J; Cepeda D; González S; Hall ER
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1279-81. PubMed ID: 21199926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
    Sader HS; Hsiung A; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):341-4. PubMed ID: 17141461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
    Mutai WC; Muigai AWT; Waiyaki P; Kariuki S
    BMC Microbiol; 2018 Nov; 18(1):187. PubMed ID: 30428828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
    Livermore DM; Yuan M
    J Antimicrob Chemother; 1996 Sep; 38(3):409-24. PubMed ID: 8889716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibilities of 23 Desulfovibrio isolates from humans.
    Nakao K; Tanaka K; Ichiishi S; Mikamo H; Shibata T; Watanabe K
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5308-11. PubMed ID: 19786606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
    Vela AI; Fernández-Garayzábal JF; Latre MV; Rodríguez AA; Domínguez L; Moreno MA
    Int J Antimicrob Agents; 2001 Mar; 17(3):215-20. PubMed ID: 11282267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods.
    Almuzara M; Limansky A; Ballerini V; Galanternik L; Famiglietti A; Vay C
    Int J Antimicrob Agents; 2010 Jan; 35(1):68-71. PubMed ID: 19889520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results.
    Nayak R; Call V; Kaldhone P; Tyler C; Anderson G; Phillips S; Kerdahi K; Foley SL
    Clin Med Res; 2007 Jun; 5(2):98-105. PubMed ID: 17607044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated direct screening for resistance of Gram-negative blood cultures using the BD Kiestra WorkCell.
    Heather CS; Maley M
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):117-125. PubMed ID: 28971266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
    Chakraborty A; Miyahara S; Villanueva SY; Gloriani NG; Yoshida S
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5403-5. PubMed ID: 20855741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.
    Karlowsky JA; Jones ME; Thornsberry C; Evangelista AT; Yee YC; Sahm DF
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S89-98. PubMed ID: 15712102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance Group.
    Murray PR; Cantrell HF; Lankford RB
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):111-20. PubMed ID: 7805355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in-vitro activity of piperacillin/tazobactam, ciprofloxacin, ceftazidime and imipenem against multiple resistant gram-negative bacteria.
    Mehtar S; Drabu YJ; Blakemore PH
    J Antimicrob Chemother; 1990 Jun; 25(6):915-9. PubMed ID: 2164513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro activity of piperacillin/tazobactam against gram-negative bacilli.
    Liebowitz LD; Klugman KP
    S Afr Med J; 1996 Oct; 86(10):1276-80. PubMed ID: 8955735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of antimicrobial resistance in an oncology center in eastern India.
    Bhattacharya S; Goel G; Mukherjee S; Bhaumik J; Chandy M
    Infect Control Hosp Epidemiol; 2015 Jul; 36(7):864-6. PubMed ID: 25899762
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro susceptibility of multi-drug resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from clinical specimens at Bugando Medical Centre, Tanzania to Piperacillin-Tazobactam.
    Petro D; Mushi MF; Moremi N; Iddi S; Mirambo M; Seni J; Mshana SE
    Tanzan J Health Res; 2014 Jan; 16(1):54-7. PubMed ID: 26867273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of piperacillin/tazobactam versus other broad-spectrum antibiotics against nosocomial gram-negative pathogens isolated from burn patients.
    Mokaddas E; Rotimi VO; Sanyal SC
    J Chemother; 1998 Jun; 10(3):208-14. PubMed ID: 9669645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles.
    Chen HY; Bonfiglio G; Allen M; Piper D; Edwardson T; McVey D; Livermore DM
    J Antimicrob Chemother; 1993 Aug; 32(2):247-66. PubMed ID: 8226427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.